Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in Haematology - PubMed (original) (raw)

Practice Guideline

. 2015 Jun;169(5):661-71.

doi: 10.1111/bjh.13403. Epub 2015 Apr 15.

Affiliations

• PMID: 25876990
• DOI: 10.1111/bjh.13403

Free article

Practice Guideline

Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in Haematology

Gail L Jones et al. Br J Haematol. 2015 Jun.

Free article

No abstract available

Keywords: chemotherapy; clinical haematology; haematological malignancy; haematological oncology; tumour lysis syndrome.

PubMed Disclaimer

Comment in

• Evolving concepts in tumour lysis syndrome management - response to Ayed et al.
  Jones GL, Will A, Jackson GH, Webb NJ, Rule S. Jones GL, et al. Br J Haematol. 2016 May;173(3):486-7. doi: 10.1111/bjh.13616. Epub 2015 Jul 27. Br J Haematol. 2016. PMID: 26216044 No abstract available.
• Evolving concepts in tumour lysis syndrome management.
  Ayed S, Bornstain C, Vincent F. Ayed S, et al. Br J Haematol. 2016 May;173(3):485-6. doi: 10.1111/bjh.13617. Epub 2015 Jul 27. Br J Haematol. 2016. PMID: 26216191 No abstract available.

Similar articles

• Evaluation of the safety and efficacy of low-dose rasburicase in critically ill children with haematological malignancies.
  Pei Y, Li Y, Liang Y, Xu L, Huang X, Li Y, Tang W, Jiang X. Pei Y, et al. Int J Clin Pharm. 2020 Dec;42(6):1440-1446. doi: 10.1007/s11096-020-01144-8. Epub 2020 Sep 24. Int J Clin Pharm. 2020. PMID: 32974856 Free PMC article.
• Tumor lysis syndrome: review of pathogenesis, risk factors and management of a medical emergency.
  Criscuolo M, Fianchi L, Dragonetti G, Pagano L. Criscuolo M, et al. Expert Rev Hematol. 2016;9(2):197-208. doi: 10.1586/17474086.2016.1127156. Epub 2016 Jan 8. Expert Rev Hematol. 2016. PMID: 26629730 Review.
• Tumour Lysis Syndrome in children with haematological cancers: Experience at a tertiary care hospital in Karachi.
  Saeed F, Ali MS, Ashraf MS, Vadsaria K, Siddiqui DE. Saeed F, et al. J Pak Med Assoc. 2018 Nov;68(11):1625-1630. J Pak Med Assoc. 2018. PMID: 30410139
• Tumor lysis syndrome as a risk factor for posterior reversible encephalopathy syndrome in children with hematological malignancies.
  Suzuki D, Kobayashi R, Iguchi A, Sano H, Kishimoto K, Yasuda K, Kobayashi K. Suzuki D, et al. Int J Hematol. 2014 Nov;100(5):485-9. doi: 10.1007/s12185-014-1658-z. Epub 2014 Sep 13. Int J Hematol. 2014. PMID: 25216697
• The clinical management of tumour lysis syndrome in haematological malignancies.
  Will A, Tholouli E. Will A, et al. Br J Haematol. 2011 Jul;154(1):3-13. doi: 10.1111/j.1365-2141.2011.08697.x. Epub 2011 May 9. Br J Haematol. 2011. PMID: 21554259 Review.

Cited by

• Evaluation of the safety and efficacy of low-dose rasburicase in critically ill children with haematological malignancies.
  Pei Y, Li Y, Liang Y, Xu L, Huang X, Li Y, Tang W, Jiang X. Pei Y, et al. Int J Clin Pharm. 2020 Dec;42(6):1440-1446. doi: 10.1007/s11096-020-01144-8. Epub 2020 Sep 24. Int J Clin Pharm. 2020. PMID: 32974856 Free PMC article.
• Tumour lysis syndrome.
  Howard SC, Avagyan A, Workeneh B, Pui CH. Howard SC, et al. Nat Rev Dis Primers. 2024 Aug 22;10(1):58. doi: 10.1038/s41572-024-00542-w. Nat Rev Dis Primers. 2024. PMID: 39174582 Review.
• Diagnosis and management of tumor lysis syndrome.
  Puri I, Sharma D, Gunturu KS, Ahmed AA. Puri I, et al. J Community Hosp Intern Med Perspect. 2020 Jun 14;10(3):269-272. doi: 10.1080/20009666.2020.1761185. J Community Hosp Intern Med Perspect. 2020. PMID: 32850076 Free PMC article. Review.
• Impact of daytime continuous veno-venous haemofiltration on treatment of paediatric tumour lysis syndrome.
  Wang Y, Lu J, Tao Y. Wang Y, et al. J Int Med Res. 2018 Sep;46(9):3613-3620. doi: 10.1177/0300060518776426. Epub 2018 Jun 8. J Int Med Res. 2018. PMID: 29882457 Free PMC article.
• Successful Use of Extracorporeal Life Support and Continuous Renal Replacement Therapy in the Treatment of Cardiogenic Shock Induced by Tumor Lysis Syndrome in a Pediatric Patient With Lymphoma: A Case Report.
  Wang Z, Zhang F, Xiang L, Yang Y, Wang W, Li B, Ren H. Wang Z, et al. Front Med (Lausanne). 2022 Jan 4;8:762788. doi: 10.3389/fmed.2021.762788. eCollection 2021. Front Med (Lausanne). 2022. PMID: 35059412 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wiley